1559 related articles for article (PubMed ID: 31485884)
1. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
Shahjin F; Chand S; Yelamanchili SV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
[TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
[TBL] [Abstract][Full Text] [Related]
3. Engineered EVs designed to target diseases of the CNS.
Nieland L; Mahjoum S; Grandell E; Breyne K; Breakefield XO
J Control Release; 2023 Apr; 356():493-506. PubMed ID: 36907561
[TBL] [Abstract][Full Text] [Related]
4. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
[TBL] [Abstract][Full Text] [Related]
5. Stem Cell-derived Extracellular Vesicles: A Promising Nano Delivery Platform to the Brain?
Guo Y; Hu D; Lian L; Zhao L; Li M; Bao H; Xu S
Stem Cell Rev Rep; 2023 Feb; 19(2):285-308. PubMed ID: 36173500
[TBL] [Abstract][Full Text] [Related]
6. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
Muhammad SA
Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review.
Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q
Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061
[TBL] [Abstract][Full Text] [Related]
9. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
10. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
[TBL] [Abstract][Full Text] [Related]
11. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
12. Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles.
Saint-Pol J; Gosselet F; Duban-Deweer S; Pottiez G; Karamanos Y
Cells; 2020 Apr; 9(4):. PubMed ID: 32244730
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances on Extracellular Vesicles in Central Nervous System Diseases.
Jin T; Gu J; Li Z; Xu Z; Gui Y
Clin Interv Aging; 2021; 16():257-274. PubMed ID: 33603351
[TBL] [Abstract][Full Text] [Related]
14. Emerging prospects of extracellular vesicles for brain disease theranostics.
Wang R; Wang X; Zhang Y; Zhao H; Cui J; Li J; Di L
J Control Release; 2022 Jan; 341():844-868. PubMed ID: 34953980
[TBL] [Abstract][Full Text] [Related]
15. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
Kooijmans SAA; de Jong OG; Schiffelers RM
Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
[TBL] [Abstract][Full Text] [Related]
16. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
[TBL] [Abstract][Full Text] [Related]
17. [Research advances in brain-targeted nanoscale drug delivery system].
Liu Y; Jiang C
Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
[TBL] [Abstract][Full Text] [Related]
18. Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles.
Zhou L; Kodidela S; Godse S; Thomas-Gooch S; Kumar A; Raji B; Zhi K; Kochat H; Kumar S
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337155
[TBL] [Abstract][Full Text] [Related]
19. Nutraceuticals in HIV and COVID-19-Related Neurological Complications: Opportunity to Use Extracellular Vesicles as Drug Delivery Modality.
Kodidela S; Godse S; Kumar A; Nguyen XH; Cernasev A; Zhou L; Singh AK; Bhat HK; Kumar S
Biology (Basel); 2022 Jan; 11(2):. PubMed ID: 35205044
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles: Critical bilateral communicators in periphery-brain crosstalk in central nervous system disorders.
Wang D; Guan S; Lu P; Li Y; Xu H
Biomed Pharmacother; 2023 Apr; 160():114354. PubMed ID: 36753954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
